Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026465291> ?p ?o ?g. }
- W2026465291 endingPage "244" @default.
- W2026465291 startingPage "239" @default.
- W2026465291 abstract "Objectives To determine the impact of adjuvant chemotherapy or pelvic radiation on risk of recurrence and outcome in stage IA non-invasive uterine papillary serous carcinoma (UPSC). Methods This is a multi-institutional retrospective study for 115 patients with stage IA non-invasive UPSC (confined to endometrium) treated between 2000 and 2012. Kaplan–Meier and multivariable Cox proportional hazards regression modeling were used. Results Staging lymphadenectomy and omentectomy were performed in 84% and 57% respectively. Recurrence was seen in 26% (30/115). Sites of recurrences were vaginal in 7.8% (9/115), pelvic in 3.5% (4/115) and extra-pelvic in 14.7% (17/115). Adjuvant chemotherapy did not impact risk of recurrence (25.5% vs. 26.9%, p = 0.85) even in subset of patients who underwent lymphadenectomy (20% vs. 23.5%, p = 0.80). These findings were consistent for pattern of recurrence. Among those who underwent lymphadenectomy, adjuvant chemotherapy did not impact progression-free survival (p = 0.34) and overall survival (p = 0.12). However among patients who did not have lymphadenectomy, adjuvant chemotherapy or pelvic radiation was associated with longer progression-free survival (p = 0.04) and overall survival (p = 0.025). In multivariable analysis, only staging lymphadenectomy was associated with improved progression-free survival (HR 0.34, 95% CI 0.12–0.95, p = 0.04) and overall survival (HR 0.35, 95% CI 0.12–1.0, p = 0.05). Neither adjuvant chemotherapy nor pelvic radiation were predictors of progression-free or overall survivals. Conclusion In stage IA non-invasive UPSC, staging lymphadenectomy was significantly associated with recurrence and outcome and therefore, should be performed in all patients. Adjuvant chemotherapy or pelvic radiation had no impact on outcome in surgically staged patients but was associated with improved outcome in unstaged patients." @default.
- W2026465291 created "2016-06-24" @default.
- W2026465291 creator A5008170385 @default.
- W2026465291 creator A5015846423 @default.
- W2026465291 creator A5019764947 @default.
- W2026465291 creator A5036827926 @default.
- W2026465291 creator A5039273020 @default.
- W2026465291 creator A5042690121 @default.
- W2026465291 creator A5044100563 @default.
- W2026465291 creator A5052303363 @default.
- W2026465291 creator A5082261707 @default.
- W2026465291 creator A5089239939 @default.
- W2026465291 creator A5090352887 @default.
- W2026465291 date "2015-05-01" @default.
- W2026465291 modified "2023-10-16" @default.
- W2026465291 title "Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study" @default.
- W2026465291 cites W1972503071 @default.
- W2026465291 cites W1973873786 @default.
- W2026465291 cites W1998466115 @default.
- W2026465291 cites W2001966656 @default.
- W2026465291 cites W2006762762 @default.
- W2026465291 cites W2016294917 @default.
- W2026465291 cites W2019897392 @default.
- W2026465291 cites W2029320934 @default.
- W2026465291 cites W2030467478 @default.
- W2026465291 cites W2030619756 @default.
- W2026465291 cites W2031910480 @default.
- W2026465291 cites W2038011108 @default.
- W2026465291 cites W2040639582 @default.
- W2026465291 cites W2046089575 @default.
- W2026465291 cites W2050484929 @default.
- W2026465291 cites W2058760459 @default.
- W2026465291 cites W2065949107 @default.
- W2026465291 cites W2075311659 @default.
- W2026465291 cites W2085953226 @default.
- W2026465291 cites W4231648378 @default.
- W2026465291 doi "https://doi.org/10.1016/j.ygyno.2015.01.544" @default.
- W2026465291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25641568" @default.
- W2026465291 hasPublicationYear "2015" @default.
- W2026465291 type Work @default.
- W2026465291 sameAs 2026465291 @default.
- W2026465291 citedByCount "17" @default.
- W2026465291 countsByYear W20264652912016 @default.
- W2026465291 countsByYear W20264652912017 @default.
- W2026465291 countsByYear W20264652912018 @default.
- W2026465291 countsByYear W20264652912020 @default.
- W2026465291 countsByYear W20264652912021 @default.
- W2026465291 countsByYear W20264652912022 @default.
- W2026465291 countsByYear W20264652912023 @default.
- W2026465291 crossrefType "journal-article" @default.
- W2026465291 hasAuthorship W2026465291A5008170385 @default.
- W2026465291 hasAuthorship W2026465291A5015846423 @default.
- W2026465291 hasAuthorship W2026465291A5019764947 @default.
- W2026465291 hasAuthorship W2026465291A5036827926 @default.
- W2026465291 hasAuthorship W2026465291A5039273020 @default.
- W2026465291 hasAuthorship W2026465291A5042690121 @default.
- W2026465291 hasAuthorship W2026465291A5044100563 @default.
- W2026465291 hasAuthorship W2026465291A5052303363 @default.
- W2026465291 hasAuthorship W2026465291A5082261707 @default.
- W2026465291 hasAuthorship W2026465291A5089239939 @default.
- W2026465291 hasAuthorship W2026465291A5090352887 @default.
- W2026465291 hasConcept C121608353 @default.
- W2026465291 hasConcept C126322002 @default.
- W2026465291 hasConcept C126894567 @default.
- W2026465291 hasConcept C141071460 @default.
- W2026465291 hasConcept C143998085 @default.
- W2026465291 hasConcept C146357865 @default.
- W2026465291 hasConcept C150173356 @default.
- W2026465291 hasConcept C151730666 @default.
- W2026465291 hasConcept C167135981 @default.
- W2026465291 hasConcept C2776694085 @default.
- W2026465291 hasConcept C2777088508 @default.
- W2026465291 hasConcept C2780824555 @default.
- W2026465291 hasConcept C2910223938 @default.
- W2026465291 hasConcept C50382708 @default.
- W2026465291 hasConcept C509974204 @default.
- W2026465291 hasConcept C71924100 @default.
- W2026465291 hasConcept C86803240 @default.
- W2026465291 hasConceptScore W2026465291C121608353 @default.
- W2026465291 hasConceptScore W2026465291C126322002 @default.
- W2026465291 hasConceptScore W2026465291C126894567 @default.
- W2026465291 hasConceptScore W2026465291C141071460 @default.
- W2026465291 hasConceptScore W2026465291C143998085 @default.
- W2026465291 hasConceptScore W2026465291C146357865 @default.
- W2026465291 hasConceptScore W2026465291C150173356 @default.
- W2026465291 hasConceptScore W2026465291C151730666 @default.
- W2026465291 hasConceptScore W2026465291C167135981 @default.
- W2026465291 hasConceptScore W2026465291C2776694085 @default.
- W2026465291 hasConceptScore W2026465291C2777088508 @default.
- W2026465291 hasConceptScore W2026465291C2780824555 @default.
- W2026465291 hasConceptScore W2026465291C2910223938 @default.
- W2026465291 hasConceptScore W2026465291C50382708 @default.
- W2026465291 hasConceptScore W2026465291C509974204 @default.
- W2026465291 hasConceptScore W2026465291C71924100 @default.
- W2026465291 hasConceptScore W2026465291C86803240 @default.
- W2026465291 hasIssue "2" @default.
- W2026465291 hasLocation W20264652911 @default.
- W2026465291 hasLocation W20264652912 @default.